Vontobel Asset Management is a global multi-boutique asset manager based in Basel, Switzerland, with a history dating back to 1924. The firm specializes in various investment strategies, including Quality Growth Equities, Multi-Asset Class, Fixed Income, Global Thematic Equities, and Alternatives, operating through independent boutiques that focus on specific areas of expertise. As of mid-2018, its investment portfolio comprised 33% multi-asset, 39% equity, and 29% fixed income. Vontobel is dedicated to expanding its Fixed Income boutique globally and enhancing its presence in the UK market. Additionally, Vontobel European Ventures, a venture capital fund located in Zurich, focuses on investments in the semiconductor and technology, media, and telecommunications sectors across Europe. In 2015, Vontobel Asset Management integrated Harcourt, which specializes in alternative investments, into its broader operational framework.
Colgate-Palmolive Company is a global consumer products firm operating in over 200 countries, focusing on two primary segments: Oral, Personal and Home Care, and Pet Nutrition. Its Oral Care portfolio features well-known products such as Colgate Total, Colgate Sensitive Pro-Relief, and various toothbrushes and mouth rinses. Additionally, the company offers dental floss and products aimed at dental professionals. In the Personal Care segment, Colgate-Palmolive markets brands like Palmolive, Softsoap, and Irish Spring, encompassing a range of shower gels, bar soaps, and deodorants. The company also provides liquid hand soaps under several brand names. Through its Hill's Pet Nutrition division, it manufactures specialized nutrition products for dogs and cats, further diversifying its offerings in the consumer products market.
Notenstein La Roche – our name stands for integrated and individual wealth management at the very highest level. Our expertise and sense of tradition come together in the personal and comprehensive advice we offer. With CHF 17 billion in assets under management, we are one of Switzerland’s leading private banks. Approximately 400 members of staff at 13 locations ensure service excellence for our clients each and every day. Our solid parent company, Raiffeisen Switzerland, is one of the biggest banks in Switzerland.
TwentyFour Asset Management is an independent fixed income specialist based in the City of London. Founded in 2008 by a group of leading fixed income professionals, we currently manage £4.3bn for our clients. We offer highly transparent products that benefit from a rigorous detail-oriented investment approach, in order to achieve superior risk-adjusted returns whilst retaining a strong focus on capital preservation.
Derivative.Com
Acquisition in 2014
Derivative.Com AG provides an online platform that allows asset managers, banks, pension funds and insurance companies, and other regulated investment professionals to compare pricings for customized structured products and trade in primary market in Switzerland and Liechtenstein.
Commerzbank (Switzerland) AG specializes in private banking and commercial banking services. The bank offers a range of financial products, including credit and debit cards, ATM services, securities management, loans, as well as savings and current accounts. With its focus on delivering comprehensive banking solutions, Commerzbank (Switzerland) caters to both individual and corporate clients, ensuring access to essential financial services tailored to meet their needs.
Harcourt Investment Consulting
Acquisition in 2005
Harcourt Investment Consulting provides consulting and advisory services. It provides its services to institutional clients.
EpiCept Corporation headquarters are located in Englewood Cliffs, New Jersey, with a subsidiary company, EpiCept GmbH in Munich Germany. This transatlantic presence facilitates access to European technology and markets and enhances financing and liquidity opportunities. EpiCept and its subsidiary are focused on developing novel, effective, safe and economical prescription pain products delivering drugs to a target area by using a topical delivery approach as opposed to systemic or transdermal modes. It is envisioned that EpiCept products will have significant market potential. The products are protected by an aggressive patent program.
MainControl® is a leading provider of e-Infrastructure management solutions that can help your company manage the technology infrastructure profitably and efficiently. Founded in 1994, MainControl provides more than 200 corporations worldwide with its industry-leading solutions to manage e-Infrastructure resources throughout the life cycle - from planning and procurement to deployment and disposal.